Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium
The Dementia with Lewy Bodies (DLB) Consortium has refined its recommendations about
the clinical and pathologic diagnosis of DLB, updating the previous report, which has been …
the clinical and pathologic diagnosis of DLB, updating the previous report, which has been …
Dementia prevention, intervention, and care
Executive summary Acting now on dementia prevention, intervention, and care will vastly
improve living and dying for individuals with dementia and their families, and in doing so …
improve living and dying for individuals with dementia and their families, and in doing so …
Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?
KA Jellinger, AD Korczyn - Advances in Surgical and Medical …, 2023 - taylorfrancis.com
The clinical features of dementia with Lewy bodies (DLB) and Parkinson's disease dementia
(PDD) are similar and include dementia, cognitive fluctuations, and (visual) hallucinations in …
(PDD) are similar and include dementia, cognitive fluctuations, and (visual) hallucinations in …
Dementia with Lewy bodies: an update and outlook
Dementia with Lewy bodies (DLB) is an age-associated neurodegenerative disorder
producing progressive cognitive decline that interferes with normal life and daily activities …
producing progressive cognitive decline that interferes with normal life and daily activities …
The use of neuroimaging techniques in the early and differential diagnosis of dementia
Dementia is a leading cause of disability and death worldwide. At present there is no
disease modifying treatment for any of the most common types of dementia such as …
disease modifying treatment for any of the most common types of dementia such as …
Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies
KA Jellinger - Journal of neural transmission, 2018 - Springer
Dementia with Lewy bodies (DLB) and Parkinson's disease-dementia (PDD), although
sharing many clinical, neurochemical and morphological features, according to DSM-5, are …
sharing many clinical, neurochemical and morphological features, according to DSM-5, are …
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium
The dementia with Lewy bodies (DLB) Consortium has revised criteria for the clinical and
pathologic diagnosis of DLB incorporating new information about the core clinical features …
pathologic diagnosis of DLB incorporating new information about the core clinical features …
Clinical practice with anti-dementia drugs: a revised (third) consensus statement from the British Association for Psychopharmacology
The British Association for Psychopharmacology coordinated a meeting of experts to review
and revise its previous 2011 guidelines for clinical practice with anti-dementia drugs. As …
and revise its previous 2011 guidelines for clinical practice with anti-dementia drugs. As …
Quantification of brain cholinergic denervation in Alzheimer's disease using PET imaging with [18F]-FEOBV
Abstract 18 F-fluoroethoxybenzovesamicol (FEOBV) is a new PET radiotracer that binds to
the vesicular acetylcholine transporter. In both animals and healthy humans, FEOBV was …
the vesicular acetylcholine transporter. In both animals and healthy humans, FEOBV was …
[HTML][HTML] Adoptive therapy with amyloid-β specific regulatory T cells alleviates Alzheimer's disease
HJ Yang, SY Park, H Baek, C Lee, G Chung, X Liu… - Theranostics, 2022 - ncbi.nlm.nih.gov
Rationale: Neuroinflammation is a primary feature of Alzheimer's disease (AD), for which an
increasing number of drugs have been specifically developed. The present study aimed to …
increasing number of drugs have been specifically developed. The present study aimed to …